secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001213900-25-072068
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics shareholders approve director re-election and plan amendment at 2025 annual meeting
--------------------------------------------------------------------------------

- All five director nominees (Knie, Sarnoff, Linsley, Pavell, Camarra) re-elected with strong support.
- Ratification of Withum as auditor for FY2025 approved: 4,559,052 for, 247,728 against.
- Amendment to 2022 Plan to increase share reserve from 1,091,317 to 3,091,317 shares approved.
- Advisory vote on 2024 executive compensation approved: 1,098,368 for, 265,965 against.
- Shareholders selected one-year frequency for future advisory votes on executive pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/0001213900-25-072068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390025072068/ea0251896-8k_hoth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-072068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer